Date & Time of Session - 9/30/25 - from 12:00 - 1:00PM

Overview
Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in oncology, with patients experiencing a markedly higher risk of both recurrent venous thromboembolism (VTE) and bleeding compared to the general population. Anticoagulation is the standard of care, but management is complicated by thrombocytopenia, which commonly results from chemotherapy, bone marrow involvement, or other cancer-related factors. This creates a clinical dilemma, as limited trial data exist to guide anticoagulation in patients with low platelet counts, and current recommendations rely largely on expert opinion. Given the frequency and complexity of these situations, there is a pressing need to clarify best practices, synthesize available evidence, and provide practical guidance to help clinicians balance thrombosis and bleeding risks in thrombocytopenic cancer patients.

Objectives
Upon completion of this activity, participants will be able to:
1. Review the epidemiology and pathophysiology of cancer-associated thrombus
2. Discuss current strategies for VTE prophylaxis and treatment in cancer patients
3. Outline the management of cancer associated thrombus in the setting of thrombocytopenia 

Target Audience
Pharmacists, residents, and students

Special Services
If you require special assistance to attend this event, please call Megan Russel at (304) 550-0896.

Speaker
Audrey Gann, PharmD
PGY2 Hematology Oncology Resident
UK College of Pharmacy - Lexington, Kentucky

Session date: 
09/30/2025 - 12:00pm EDT to 11/28/2025 - 11:59pm EST
Add to calendar: 
  • 1.00 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Audrey Gann, PharmD

has no relevant financial relationships to disclose at this time.